IFNG and skin cancer: Meanwhile, the IO-related transcriptomic biomarker IFN gamma score was not statistically different between HRD samples and HRP samples across all skin cancer subtypes except in squamous cell carcinoma where HRD shows a significant decrease in IFN gamma scores (−0.29 v −0.15, P = .0015; Fig 2E).